PhnyX Lab Secures $4 Million in Seed Funding Led by SK Networks

PhnyX Lab has successfully closed a $4 million seed funding round, announced in a press release. The round was led by SK Networks, with participation from prominent angel investors including Aidan Gomez, co-founder and CEO of Cohere, and Illia Polosukhin, co-founder of NEAR Protocol.

The funding will support the expansion of PhnyX Lab's flagship platform, Cheiron, which launched in December 2024. Cheiron is already utilized by over 60 companies, including Korea's top 10 pharmaceutical firms, to streamline complex workflows such as research paper and clinical trial searches. Building on this momentum, PhnyX Lab is expanding Cheiron into a broader product suite, including Cheiron Write, designed to automate medical writing processes.

This investment marks a significant milestone for PhnyX Lab as it aims to transform manual pharmaceutical processes into intelligent, integrated workflows, enhancing efficiency in drug discovery and approval processes.